Cholesterol Efflux Capacity and Atherosclerosis

被引：0

作者：

Asleh, Rabea ^{[1
]}

Levy, Andrew P. ^{[1
]}

Blum, Shany ^{[1
]}

机构：

[1] Technion Israel Inst Technol, Fac Med, Haifa, Israel

来源：

关键词：

CARDIOVASCULAR-DISEASE; INDIVIDUALS; GENOTYPE; HDL;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1473 / 1473

页数：1

共 4 条

[1] Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype
Asleh, Rabea
Blum, Shany
Kalet-Litman, Shiri
Alshiek, Jonia
Miller-Lotan, Rachel
Asaf, Roy
Rock, Wasseem
Aviram, Michael
Milman, Uzi
Shapira, Chen
Abassi, Zaid
Levy, Andrew P.
[J]. DIABETES, 2008, 57 (10) : 2794 - 2800
[2] Blum S, 2010, PHARMACOGENOMICS, V11, P675, DOI [10.2217/pgs.10.17, 10.2217/PGS.10.17]
[3] HDL and Cardiovascular-Disease Risk - Time for a New Approach?
Heinecke, Jay
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (02) : 170 - 171
[4] Haptoglobin: Basic and Clinical Aspects
Levy, Andrew P.
Asleh, Rabea
Blum, Shany
Levy, Nina S.
Miller-Lotan, Rachel
Kalet-Litman, Shiri
Anbinder, Yefim
Lache, Orit
Nakhoul, Farid M.
Asaf, Roy
Farbstein, Dan
Pollak, Mordechai
Soloveichik, Yitzhak Z.
Strauss, Merav
Alshiek, Jonia
Livshits, Alina
Schwartz, Avery
Awad, Hoda
Jad, Kheir
Goldenstein, Hagit
[J]. ANTIOXIDANTS & REDOX SIGNALING, 2010, 12 (02) : 293 - 304